I'm not completely clear on what you're saying, bu
Post# of 30013
![Avatar](/images/ProfileImages/no_avatar_available.jpg)
As for a "commercial DX"
GC said in the January presentation that "MSPrecise is our lead commercial diagnostic via CLIA in 2015"
LymPro intinal target market is $150mm for IUO
Upcoming Milestones for LymPro are
1) First pharmaceutical Biomarker customer sales
2) CLIA Certification
3) CE Mark
4) FDA Pathway evaluation
So, again, I don't understand what you're pointing out.
Cheers
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)